Comparative Study of Triamcinolone Acetonide and Hydrocortisone 17-Butyrate in Rosacea with Special Regard to the Rebound Phenomenon
作者:
M.J.Th.H. Go,
J. Wuite,
期刊:
Dermatology
(Karger Available online 1976)
卷期:
Volume 152,
issue 1
页码: 239-246
ISSN:1018-8665
年代: 1976
DOI:10.1159/000257895
出版商: S. Karger AG
关键词: Corticosteroids;Rosacea;Rebound phenomenon
数据来源: Karger
摘要:
The clinical efficacy and the rebound phenomenon were studied in a left-right double-blind trial comparing triamcinolone acetonide (TA) and hydrocortisone 17-butyrate (HC 17-B, Locoid®). The trial comprised 19 patients with rosacea-like dermatitis of whom 7 did not receive treatment and 12 were pretreated with betamethasone valerate (BMV). Tetracycline was given all the time as additional treatment. Clinically there was no significant difference between TA and HC 17-B. No rebound phenomenon was observed. If corticosteroids are to be used at all in rosacea or rosacea-like dermatitis, preference is given to HC 17-B
点击下载:
PDF
(1533KB)
返 回